Comparing early versus delayed exercise therapy after breast cancer surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will evaluate the effects of initiating specific exercise therapy either within the first week or at three weeks after breast cancer surgery. The primary focus is to determine which timing leads to better upper limb function at six months, assessed using the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire. Secondary outcomes include measuring pain intensity and monitoring wound-related complications. The study aims to provide insights into optimal rehabilitation timing for post-surgical breast cancer patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women aged 18-65 years.
* Scheduled to undergo breast cancer surgery with axillary node dissection.
* At risk for upper limb morbidity based on preoperative assessment.
* Able to provide informed consent and complete study questionnaires.
* Willing and able to attend scheduled physiotherapy sessions and follow-up evaluations.

Exclusion Criteria:

* Diagnosis of recurrent or metastatic breast cancer.
* Concurrent participation in another rehabilitation intervention or clinical trial.
* Severe comorbidities (e.g., uncontrolled cardiovascular disease, severe orthopedic conditions) that preclude safe participation.
* History of previous shoulder surgery or chronic upper extremity musculoskeletal disorders unrelated to breast cancer treatment.
* Inability to understand or complete study materials in English.
* Pregnancy or lactation.

Where it's running

• Faculty of Physical Therapy, Al Hayah University
  Cairo, Egypt Recruiting

Study contacts

• Study coordinator: Mohamed ElMeligie, Ph.D
• Email: mohamed.elmeligie@ahuc.edu.eg
• Phone: 01159880001

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.